| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.3 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.12 | 0.7 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.12 | 0.7 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.3 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.1 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.2 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.05 |